PedAM
Pediatric Disease Annotations & Medicines
| Disease | colorectal neoplasms |
| Phenotype | C0021831|bowel disease |
| Sentences | 11 |
| PubMedID- 23347191 | Background: current approaches to the detection of colorectal neoplasia associated with inflammatory bowel disease (ibd-crn) are suboptimal. |
| PubMedID- 26063242 | Overexpression of p53 predicts colorectal neoplasia risk in patients with inflammatory bowel disease and mucosa changes indefinite for dysplasia. |
| PubMedID- 25569733 | Risk for colorectal neoplasia in patients with inflammatory bowel disease and mucosa indefinite for dysplasia. |
| PubMedID- 24477467 | Opinion statement: endoscopic surveillance is an important method to identify colorectal neoplasia in patients with inflammatory bowel disease. |
| PubMedID- 23583483 | The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. |
| PubMedID- 25350634 | Chronic inflammation plays a key role in the pathogenesis of colorectal neoplasia (crn) associated with inflammatory bowel disease, but it is not clear whether inflammation is a cause or an effect of tumours in sporadic crn. |
| PubMedID- 24312308 | Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis. |
| PubMedID- 21602529 | Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease. |
| PubMedID- 22271441 | Do thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease or is this an unanswerable question. |
| PubMedID- 22117640 | Patients with inflammatory bowel disease are at risk of colorectal neoplasia. |
| PubMedID- 25230162 | Background: the cost-effectiveness of annual colonoscopy for detection of colorectal neoplasia among patients with inflammatory bowel disease (ibd) and primary sclerosing cholangitis (psc) is uncertain. |
Page: 1